nodes	percent_of_prediction	percent_of_DWPC	metapath
Sitagliptin—ABCB1—Mitoxantrone—lymphatic system cancer	0.129	0.207	CbGbCtD
Sitagliptin—CYP3A4—Cytarabine—lymphatic system cancer	0.112	0.18	CbGbCtD
Sitagliptin—CYP3A4—Teniposide—lymphatic system cancer	0.11	0.177	CbGbCtD
Sitagliptin—ABCB1—Vincristine—lymphatic system cancer	0.0887	0.142	CbGbCtD
Sitagliptin—CYP3A4—Mitoxantrone—lymphatic system cancer	0.0772	0.124	CbGbCtD
Sitagliptin—ABCB1—Methotrexate—lymphatic system cancer	0.0537	0.086	CbGbCtD
Sitagliptin—CYP3A4—Vincristine—lymphatic system cancer	0.0532	0.0852	CbGbCtD
Sitagliptin—Erythema multiforme—Fludarabine—lymphatic system cancer	0.00232	0.00617	CcSEcCtD
Sitagliptin—Renal failure acute—Mitoxantrone—lymphatic system cancer	0.00229	0.00608	CcSEcCtD
Sitagliptin—Face oedema—Carmustine—lymphatic system cancer	0.00219	0.00583	CcSEcCtD
Sitagliptin—Pain in extremity—Vincristine—lymphatic system cancer	0.00217	0.00576	CcSEcCtD
Sitagliptin—Malnutrition—Fludarabine—lymphatic system cancer	0.00214	0.00568	CcSEcCtD
Sitagliptin—Hypertension—Teniposide—lymphatic system cancer	0.0021	0.00558	CcSEcCtD
Sitagliptin—Lung disorder—Methotrexate—lymphatic system cancer	0.00205	0.00544	CcSEcCtD
Sitagliptin—Pneumonia—Bleomycin—lymphatic system cancer	0.00202	0.00536	CcSEcCtD
Sitagliptin—Hypersensitivity—Mechlorethamine—lymphatic system cancer	0.00198	0.00527	CcSEcCtD
Sitagliptin—Ill-defined disorder—Fludarabine—lymphatic system cancer	0.00198	0.00527	CcSEcCtD
Sitagliptin—Blood creatinine increased—Mitoxantrone—lymphatic system cancer	0.00198	0.00526	CcSEcCtD
Sitagliptin—Infection—Teniposide—lymphatic system cancer	0.00197	0.00524	CcSEcCtD
Sitagliptin—Abdominal pain upper—Mitoxantrone—lymphatic system cancer	0.00193	0.00513	CcSEcCtD
Sitagliptin—Malaise—Fludarabine—lymphatic system cancer	0.00193	0.00512	CcSEcCtD
Sitagliptin—Herpes zoster—Methotrexate—lymphatic system cancer	0.00192	0.00512	CcSEcCtD
Sitagliptin—Cough—Fludarabine—lymphatic system cancer	0.00186	0.00496	CcSEcCtD
Sitagliptin—Diarrhoea—Mechlorethamine—lymphatic system cancer	0.00184	0.0049	CcSEcCtD
Sitagliptin—Arthralgia—Fludarabine—lymphatic system cancer	0.00182	0.00484	CcSEcCtD
Sitagliptin—Myalgia—Fludarabine—lymphatic system cancer	0.00182	0.00484	CcSEcCtD
Sitagliptin—Discomfort—Fludarabine—lymphatic system cancer	0.0018	0.00478	CcSEcCtD
Sitagliptin—Hypoaesthesia—Bleomycin—lymphatic system cancer	0.00179	0.00476	CcSEcCtD
Sitagliptin—Hyperglycaemia—Carmustine—lymphatic system cancer	0.00177	0.00471	CcSEcCtD
Sitagliptin—Pneumonia—Carmustine—lymphatic system cancer	0.00176	0.00468	CcSEcCtD
Sitagliptin—Depression—Carmustine—lymphatic system cancer	0.00174	0.00464	CcSEcCtD
Sitagliptin—Anaphylactic shock—Fludarabine—lymphatic system cancer	0.00174	0.00464	CcSEcCtD
Sitagliptin—Infection—Fludarabine—lymphatic system cancer	0.00173	0.00461	CcSEcCtD
Sitagliptin—Erectile dysfunction—Vincristine—lymphatic system cancer	0.00172	0.00459	CcSEcCtD
Sitagliptin—Decreased appetite—Teniposide—lymphatic system cancer	0.00172	0.00459	CcSEcCtD
Sitagliptin—Renal failure—Carmustine—lymphatic system cancer	0.00172	0.00457	CcSEcCtD
Sitagliptin—Neuropathy peripheral—Carmustine—lymphatic system cancer	0.00171	0.00456	CcSEcCtD
Sitagliptin—Vomiting—Mechlorethamine—lymphatic system cancer	0.00171	0.00455	CcSEcCtD
Sitagliptin—Nervous system disorder—Fludarabine—lymphatic system cancer	0.00171	0.00455	CcSEcCtD
Sitagliptin—Urinary tract infection—Carmustine—lymphatic system cancer	0.0017	0.00452	CcSEcCtD
Sitagliptin—Rash—Mechlorethamine—lymphatic system cancer	0.0017	0.00451	CcSEcCtD
Sitagliptin—Upper respiratory tract infection—Mitoxantrone—lymphatic system cancer	0.00169	0.00451	CcSEcCtD
Sitagliptin—Dermatitis—Mechlorethamine—lymphatic system cancer	0.00169	0.00451	CcSEcCtD
Sitagliptin—Erectile dysfunction—Mitoxantrone—lymphatic system cancer	0.00168	0.00447	CcSEcCtD
Sitagliptin—Pneumonia—Vincristine—lymphatic system cancer	0.00168	0.00447	CcSEcCtD
Sitagliptin—Depression—Vincristine—lymphatic system cancer	0.00166	0.00443	CcSEcCtD
Sitagliptin—Weight increased—Mitoxantrone—lymphatic system cancer	0.00166	0.00442	CcSEcCtD
Sitagliptin—Hyperglycaemia—Mitoxantrone—lymphatic system cancer	0.00164	0.00438	CcSEcCtD
Sitagliptin—Neuropathy peripheral—Vincristine—lymphatic system cancer	0.00164	0.00435	CcSEcCtD
Sitagliptin—Pneumonia—Mitoxantrone—lymphatic system cancer	0.00164	0.00435	CcSEcCtD
Sitagliptin—Feeling abnormal—Teniposide—lymphatic system cancer	0.00163	0.00435	CcSEcCtD
Sitagliptin—Gastrointestinal pain—Teniposide—lymphatic system cancer	0.00162	0.00431	CcSEcCtD
Sitagliptin—Renal failure—Mitoxantrone—lymphatic system cancer	0.0016	0.00425	CcSEcCtD
Sitagliptin—Nausea—Mechlorethamine—lymphatic system cancer	0.0016	0.00425	CcSEcCtD
Sitagliptin—Musculoskeletal discomfort—Fludarabine—lymphatic system cancer	0.00159	0.00422	CcSEcCtD
Sitagliptin—Urinary tract infection—Mitoxantrone—lymphatic system cancer	0.00158	0.00421	CcSEcCtD
Sitagliptin—Urticaria—Teniposide—lymphatic system cancer	0.00158	0.00419	CcSEcCtD
Sitagliptin—Abdominal pain—Teniposide—lymphatic system cancer	0.00157	0.00417	CcSEcCtD
Sitagliptin—Hypoaesthesia—Carmustine—lymphatic system cancer	0.00156	0.00416	CcSEcCtD
Sitagliptin—Oedema peripheral—Carmustine—lymphatic system cancer	0.00155	0.00412	CcSEcCtD
Sitagliptin—Connective tissue disorder—Carmustine—lymphatic system cancer	0.00154	0.0041	CcSEcCtD
Sitagliptin—Dyspepsia—Fludarabine—lymphatic system cancer	0.00153	0.00408	CcSEcCtD
Sitagliptin—Sinusitis—Mitoxantrone—lymphatic system cancer	0.00153	0.00406	CcSEcCtD
Sitagliptin—Decreased appetite—Fludarabine—lymphatic system cancer	0.00151	0.00403	CcSEcCtD
Sitagliptin—Gastrointestinal disorder—Fludarabine—lymphatic system cancer	0.0015	0.004	CcSEcCtD
Sitagliptin—Fatigue—Fludarabine—lymphatic system cancer	0.0015	0.004	CcSEcCtD
Sitagliptin—Hypoaesthesia—Vincristine—lymphatic system cancer	0.00149	0.00397	CcSEcCtD
Sitagliptin—Pain—Fludarabine—lymphatic system cancer	0.00149	0.00397	CcSEcCtD
Sitagliptin—Constipation—Fludarabine—lymphatic system cancer	0.00149	0.00397	CcSEcCtD
Sitagliptin—Urinary tract disorder—Vincristine—lymphatic system cancer	0.00148	0.00394	CcSEcCtD
Sitagliptin—Connective tissue disorder—Vincristine—lymphatic system cancer	0.00147	0.00392	CcSEcCtD
Sitagliptin—Urethral disorder—Vincristine—lymphatic system cancer	0.00147	0.00391	CcSEcCtD
Sitagliptin—Eye disorder—Carmustine—lymphatic system cancer	0.00147	0.0039	CcSEcCtD
Sitagliptin—Hypersensitivity—Teniposide—lymphatic system cancer	0.00146	0.00389	CcSEcCtD
Sitagliptin—Ill-defined disorder—Bleomycin—lymphatic system cancer	0.00145	0.00387	CcSEcCtD
Sitagliptin—Pharyngitis—Mitoxantrone—lymphatic system cancer	0.00145	0.00385	CcSEcCtD
Sitagliptin—Feeling abnormal—Fludarabine—lymphatic system cancer	0.00144	0.00382	CcSEcCtD
Sitagliptin—Asthenia—Teniposide—lymphatic system cancer	0.00142	0.00379	CcSEcCtD
Sitagliptin—Malaise—Bleomycin—lymphatic system cancer	0.00141	0.00376	CcSEcCtD
Sitagliptin—Cardiac disorder—Vincristine—lymphatic system cancer	0.00139	0.0037	CcSEcCtD
Sitagliptin—Mental disorder—Carmustine—lymphatic system cancer	0.00138	0.00366	CcSEcCtD
Sitagliptin—Malnutrition—Carmustine—lymphatic system cancer	0.00137	0.00364	CcSEcCtD
Sitagliptin—Cough—Bleomycin—lymphatic system cancer	0.00137	0.00364	CcSEcCtD
Sitagliptin—Angiopathy—Vincristine—lymphatic system cancer	0.00136	0.00362	CcSEcCtD
Sitagliptin—Diarrhoea—Teniposide—lymphatic system cancer	0.00136	0.00361	CcSEcCtD
Sitagliptin—Mediastinal disorder—Vincristine—lymphatic system cancer	0.00135	0.00359	CcSEcCtD
Sitagliptin—Myalgia—Bleomycin—lymphatic system cancer	0.00133	0.00355	CcSEcCtD
Sitagliptin—Back pain—Carmustine—lymphatic system cancer	0.00132	0.00352	CcSEcCtD
Sitagliptin—Discomfort—Bleomycin—lymphatic system cancer	0.00132	0.0035	CcSEcCtD
Sitagliptin—Mental disorder—Vincristine—lymphatic system cancer	0.00131	0.00349	CcSEcCtD
Sitagliptin—Vision blurred—Carmustine—lymphatic system cancer	0.00129	0.00343	CcSEcCtD
Sitagliptin—Hypersensitivity—Fludarabine—lymphatic system cancer	0.00128	0.00342	CcSEcCtD
Sitagliptin—Anaphylactic shock—Bleomycin—lymphatic system cancer	0.00128	0.0034	CcSEcCtD
Sitagliptin—Infection—Bleomycin—lymphatic system cancer	0.00127	0.00338	CcSEcCtD
Sitagliptin—Back pain—Vincristine—lymphatic system cancer	0.00126	0.00336	CcSEcCtD
Sitagliptin—Vomiting—Teniposide—lymphatic system cancer	0.00126	0.00335	CcSEcCtD
Sitagliptin—Asthenia—Fludarabine—lymphatic system cancer	0.00125	0.00333	CcSEcCtD
Sitagliptin—Rash—Teniposide—lymphatic system cancer	0.00125	0.00333	CcSEcCtD
Sitagliptin—Dermatitis—Teniposide—lymphatic system cancer	0.00125	0.00332	CcSEcCtD
Sitagliptin—Headache—Teniposide—lymphatic system cancer	0.00124	0.00331	CcSEcCtD
Sitagliptin—Back pain—Mitoxantrone—lymphatic system cancer	0.00123	0.00327	CcSEcCtD
Sitagliptin—Vision blurred—Mitoxantrone—lymphatic system cancer	0.0012	0.00319	CcSEcCtD
Sitagliptin—Diarrhoea—Fludarabine—lymphatic system cancer	0.00119	0.00317	CcSEcCtD
Sitagliptin—Hypertension—Carmustine—lymphatic system cancer	0.00118	0.00314	CcSEcCtD
Sitagliptin—Ill-defined disorder—Mitoxantrone—lymphatic system cancer	0.00118	0.00314	CcSEcCtD
Sitagliptin—Nausea—Teniposide—lymphatic system cancer	0.00118	0.00313	CcSEcCtD
Sitagliptin—Vertigo—Vincristine—lymphatic system cancer	0.00117	0.00312	CcSEcCtD
Sitagliptin—Musculoskeletal discomfort—Bleomycin—lymphatic system cancer	0.00116	0.0031	CcSEcCtD
Sitagliptin—Myalgia—Carmustine—lymphatic system cancer	0.00116	0.0031	CcSEcCtD
Sitagliptin—Anxiety—Carmustine—lymphatic system cancer	0.00116	0.00309	CcSEcCtD
Sitagliptin—Malaise—Mitoxantrone—lymphatic system cancer	0.00115	0.00305	CcSEcCtD
Sitagliptin—Renal failure acute—Methotrexate—lymphatic system cancer	0.00114	0.00303	CcSEcCtD
Sitagliptin—Hypertension—Vincristine—lymphatic system cancer	0.00113	0.003	CcSEcCtD
Sitagliptin—Decreased appetite—Bleomycin—lymphatic system cancer	0.00111	0.00296	CcSEcCtD
Sitagliptin—Myalgia—Vincristine—lymphatic system cancer	0.00111	0.00296	CcSEcCtD
Sitagliptin—Cough—Mitoxantrone—lymphatic system cancer	0.00111	0.00295	CcSEcCtD
Sitagliptin—Infection—Carmustine—lymphatic system cancer	0.00111	0.00295	CcSEcCtD
Sitagliptin—Vomiting—Fludarabine—lymphatic system cancer	0.00111	0.00295	CcSEcCtD
Sitagliptin—Rash—Fludarabine—lymphatic system cancer	0.0011	0.00292	CcSEcCtD
Sitagliptin—Dermatitis—Fludarabine—lymphatic system cancer	0.0011	0.00292	CcSEcCtD
Sitagliptin—Hypertension—Mitoxantrone—lymphatic system cancer	0.0011	0.00292	CcSEcCtD
Sitagliptin—Pain—Bleomycin—lymphatic system cancer	0.00109	0.00291	CcSEcCtD
Sitagliptin—Headache—Fludarabine—lymphatic system cancer	0.00109	0.00291	CcSEcCtD
Sitagliptin—Arthralgia—Mitoxantrone—lymphatic system cancer	0.00108	0.00288	CcSEcCtD
Sitagliptin—Myalgia—Mitoxantrone—lymphatic system cancer	0.00108	0.00288	CcSEcCtD
Sitagliptin—Anxiety—Mitoxantrone—lymphatic system cancer	0.00108	0.00287	CcSEcCtD
Sitagliptin—Discomfort—Mitoxantrone—lymphatic system cancer	0.00107	0.00284	CcSEcCtD
Sitagliptin—Anaphylactic shock—Vincristine—lymphatic system cancer	0.00106	0.00283	CcSEcCtD
Sitagliptin—Infection—Vincristine—lymphatic system cancer	0.00106	0.00281	CcSEcCtD
Sitagliptin—Feeling abnormal—Bleomycin—lymphatic system cancer	0.00105	0.0028	CcSEcCtD
Sitagliptin—Osteoarthritis—Methotrexate—lymphatic system cancer	0.00105	0.0028	CcSEcCtD
Sitagliptin—Nervous system disorder—Vincristine—lymphatic system cancer	0.00104	0.00278	CcSEcCtD
Sitagliptin—Anaphylactic shock—Mitoxantrone—lymphatic system cancer	0.00104	0.00276	CcSEcCtD
Sitagliptin—Nausea—Fludarabine—lymphatic system cancer	0.00104	0.00275	CcSEcCtD
Sitagliptin—Infection—Mitoxantrone—lymphatic system cancer	0.00103	0.00274	CcSEcCtD
Sitagliptin—Musculoskeletal discomfort—Carmustine—lymphatic system cancer	0.00102	0.0027	CcSEcCtD
Sitagliptin—Urticaria—Bleomycin—lymphatic system cancer	0.00102	0.0027	CcSEcCtD
Sitagliptin—Insomnia—Carmustine—lymphatic system cancer	0.00101	0.00268	CcSEcCtD
Sitagliptin—Skin disorder—Mitoxantrone—lymphatic system cancer	0.00101	0.00268	CcSEcCtD
Sitagliptin—Somnolence—Carmustine—lymphatic system cancer	0.000992	0.00264	CcSEcCtD
Sitagliptin—Musculoskeletal discomfort—Vincristine—lymphatic system cancer	0.00097	0.00258	CcSEcCtD
Sitagliptin—Decreased appetite—Carmustine—lymphatic system cancer	0.00097	0.00258	CcSEcCtD
Sitagliptin—Insomnia—Vincristine—lymphatic system cancer	0.000963	0.00256	CcSEcCtD
Sitagliptin—Gastrointestinal disorder—Carmustine—lymphatic system cancer	0.000963	0.00256	CcSEcCtD
Sitagliptin—Pain—Carmustine—lymphatic system cancer	0.000954	0.00254	CcSEcCtD
Sitagliptin—Constipation—Carmustine—lymphatic system cancer	0.000954	0.00254	CcSEcCtD
Sitagliptin—Breast disorder—Methotrexate—lymphatic system cancer	0.00095	0.00253	CcSEcCtD
Sitagliptin—Musculoskeletal discomfort—Mitoxantrone—lymphatic system cancer	0.000945	0.00251	CcSEcCtD
Sitagliptin—Hypersensitivity—Bleomycin—lymphatic system cancer	0.000941	0.0025	CcSEcCtD
Sitagliptin—Decreased appetite—Vincristine—lymphatic system cancer	0.000926	0.00246	CcSEcCtD
Sitagliptin—Somnolence—Mitoxantrone—lymphatic system cancer	0.000922	0.00245	CcSEcCtD
Sitagliptin—Gastrointestinal disorder—Vincristine—lymphatic system cancer	0.000919	0.00245	CcSEcCtD
Sitagliptin—Feeling abnormal—Carmustine—lymphatic system cancer	0.000919	0.00245	CcSEcCtD
Sitagliptin—Fatigue—Vincristine—lymphatic system cancer	0.000918	0.00244	CcSEcCtD
Sitagliptin—Asthenia—Bleomycin—lymphatic system cancer	0.000917	0.00244	CcSEcCtD
Sitagliptin—Dyspepsia—Mitoxantrone—lymphatic system cancer	0.000913	0.00243	CcSEcCtD
Sitagliptin—Gastrointestinal pain—Carmustine—lymphatic system cancer	0.000912	0.00243	CcSEcCtD
Sitagliptin—Constipation—Vincristine—lymphatic system cancer	0.000911	0.00242	CcSEcCtD
Sitagliptin—Pain—Vincristine—lymphatic system cancer	0.000911	0.00242	CcSEcCtD
Sitagliptin—Decreased appetite—Mitoxantrone—lymphatic system cancer	0.000901	0.0024	CcSEcCtD
Sitagliptin—Fatigue—Mitoxantrone—lymphatic system cancer	0.000894	0.00238	CcSEcCtD
Sitagliptin—Pancreatitis—Methotrexate—lymphatic system cancer	0.000891	0.00237	CcSEcCtD
Sitagliptin—Pain—Mitoxantrone—lymphatic system cancer	0.000887	0.00236	CcSEcCtD
Sitagliptin—Constipation—Mitoxantrone—lymphatic system cancer	0.000887	0.00236	CcSEcCtD
Sitagliptin—Abdominal pain—Carmustine—lymphatic system cancer	0.000882	0.00235	CcSEcCtD
Sitagliptin—Abdominal discomfort—Methotrexate—lymphatic system cancer	0.000871	0.00232	CcSEcCtD
Sitagliptin—Gastrointestinal pain—Vincristine—lymphatic system cancer	0.000871	0.00232	CcSEcCtD
Sitagliptin—Feeling abnormal—Mitoxantrone—lymphatic system cancer	0.000854	0.00227	CcSEcCtD
Sitagliptin—Gastrointestinal pain—Mitoxantrone—lymphatic system cancer	0.000848	0.00226	CcSEcCtD
Sitagliptin—Upper respiratory tract infection—Methotrexate—lymphatic system cancer	0.000844	0.00225	CcSEcCtD
Sitagliptin—Abdominal pain—Vincristine—lymphatic system cancer	0.000842	0.00224	CcSEcCtD
Sitagliptin—Erectile dysfunction—Methotrexate—lymphatic system cancer	0.000837	0.00223	CcSEcCtD
Sitagliptin—Urticaria—Mitoxantrone—lymphatic system cancer	0.000824	0.00219	CcSEcCtD
Sitagliptin—Hypersensitivity—Carmustine—lymphatic system cancer	0.000822	0.00219	CcSEcCtD
Sitagliptin—Abdominal pain—Mitoxantrone—lymphatic system cancer	0.00082	0.00218	CcSEcCtD
Sitagliptin—Pneumonia—Methotrexate—lymphatic system cancer	0.000815	0.00217	CcSEcCtD
Sitagliptin—Vomiting—Bleomycin—lymphatic system cancer	0.000812	0.00216	CcSEcCtD
Sitagliptin—Infestation NOS—Methotrexate—lymphatic system cancer	0.00081	0.00216	CcSEcCtD
Sitagliptin—Infestation—Methotrexate—lymphatic system cancer	0.00081	0.00216	CcSEcCtD
Sitagliptin—Depression—Methotrexate—lymphatic system cancer	0.000808	0.00215	CcSEcCtD
Sitagliptin—Rash—Bleomycin—lymphatic system cancer	0.000806	0.00214	CcSEcCtD
Sitagliptin—Dermatitis—Bleomycin—lymphatic system cancer	0.000805	0.00214	CcSEcCtD
Sitagliptin—Stevens-Johnson syndrome—Methotrexate—lymphatic system cancer	0.000803	0.00214	CcSEcCtD
Sitagliptin—Asthenia—Carmustine—lymphatic system cancer	0.0008	0.00213	CcSEcCtD
Sitagliptin—Renal failure—Methotrexate—lymphatic system cancer	0.000796	0.00212	CcSEcCtD
Sitagliptin—Hypersensitivity—Vincristine—lymphatic system cancer	0.000784	0.00209	CcSEcCtD
Sitagliptin—Hepatobiliary disease—Methotrexate—lymphatic system cancer	0.000766	0.00204	CcSEcCtD
Sitagliptin—Hypersensitivity—Mitoxantrone—lymphatic system cancer	0.000764	0.00203	CcSEcCtD
Sitagliptin—Asthenia—Vincristine—lymphatic system cancer	0.000764	0.00203	CcSEcCtD
Sitagliptin—Diarrhoea—Carmustine—lymphatic system cancer	0.000763	0.00203	CcSEcCtD
Sitagliptin—Nausea—Bleomycin—lymphatic system cancer	0.000759	0.00202	CcSEcCtD
Sitagliptin—Asthenia—Mitoxantrone—lymphatic system cancer	0.000744	0.00198	CcSEcCtD
Sitagliptin—Dizziness—Carmustine—lymphatic system cancer	0.000738	0.00196	CcSEcCtD
Sitagliptin—Diarrhoea—Vincristine—lymphatic system cancer	0.000729	0.00194	CcSEcCtD
Sitagliptin—Pharyngitis—Methotrexate—lymphatic system cancer	0.000722	0.00192	CcSEcCtD
Sitagliptin—Urinary tract disorder—Methotrexate—lymphatic system cancer	0.000718	0.00191	CcSEcCtD
Sitagliptin—Urethral disorder—Methotrexate—lymphatic system cancer	0.000713	0.0019	CcSEcCtD
Sitagliptin—Diarrhoea—Mitoxantrone—lymphatic system cancer	0.000709	0.00189	CcSEcCtD
Sitagliptin—Vomiting—Carmustine—lymphatic system cancer	0.000709	0.00189	CcSEcCtD
Sitagliptin—Dizziness—Vincristine—lymphatic system cancer	0.000704	0.00187	CcSEcCtD
Sitagliptin—Rash—Carmustine—lymphatic system cancer	0.000703	0.00187	CcSEcCtD
Sitagliptin—Dermatitis—Carmustine—lymphatic system cancer	0.000703	0.00187	CcSEcCtD
Sitagliptin—Headache—Carmustine—lymphatic system cancer	0.000699	0.00186	CcSEcCtD
Sitagliptin—Erythema multiforme—Methotrexate—lymphatic system cancer	0.000688	0.00183	CcSEcCtD
Sitagliptin—Eye disorder—Methotrexate—lymphatic system cancer	0.00068	0.00181	CcSEcCtD
Sitagliptin—Vomiting—Vincristine—lymphatic system cancer	0.000677	0.0018	CcSEcCtD
Sitagliptin—Cardiac disorder—Methotrexate—lymphatic system cancer	0.000675	0.0018	CcSEcCtD
Sitagliptin—Rash—Vincristine—lymphatic system cancer	0.000671	0.00179	CcSEcCtD
Sitagliptin—Dermatitis—Vincristine—lymphatic system cancer	0.000671	0.00178	CcSEcCtD
Sitagliptin—Headache—Vincristine—lymphatic system cancer	0.000667	0.00177	CcSEcCtD
Sitagliptin—Nausea—Carmustine—lymphatic system cancer	0.000663	0.00176	CcSEcCtD
Sitagliptin—Angiopathy—Methotrexate—lymphatic system cancer	0.00066	0.00176	CcSEcCtD
Sitagliptin—Vomiting—Mitoxantrone—lymphatic system cancer	0.000659	0.00175	CcSEcCtD
Sitagliptin—Immune system disorder—Methotrexate—lymphatic system cancer	0.000657	0.00175	CcSEcCtD
Sitagliptin—Mediastinal disorder—Methotrexate—lymphatic system cancer	0.000655	0.00174	CcSEcCtD
Sitagliptin—Rash—Mitoxantrone—lymphatic system cancer	0.000654	0.00174	CcSEcCtD
Sitagliptin—Dermatitis—Mitoxantrone—lymphatic system cancer	0.000653	0.00174	CcSEcCtD
Sitagliptin—Headache—Mitoxantrone—lymphatic system cancer	0.00065	0.00173	CcSEcCtD
Sitagliptin—Mental disorder—Methotrexate—lymphatic system cancer	0.000637	0.0017	CcSEcCtD
Sitagliptin—Malnutrition—Methotrexate—lymphatic system cancer	0.000633	0.00168	CcSEcCtD
Sitagliptin—Nausea—Vincristine—lymphatic system cancer	0.000632	0.00168	CcSEcCtD
Sitagliptin—Nausea—Mitoxantrone—lymphatic system cancer	0.000616	0.00164	CcSEcCtD
Sitagliptin—Back pain—Methotrexate—lymphatic system cancer	0.000612	0.00163	CcSEcCtD
Sitagliptin—Vision blurred—Methotrexate—lymphatic system cancer	0.000597	0.00159	CcSEcCtD
Sitagliptin—Ill-defined disorder—Methotrexate—lymphatic system cancer	0.000587	0.00156	CcSEcCtD
Sitagliptin—Malaise—Methotrexate—lymphatic system cancer	0.000571	0.00152	CcSEcCtD
Sitagliptin—Vertigo—Methotrexate—lymphatic system cancer	0.000569	0.00151	CcSEcCtD
Sitagliptin—Cough—Methotrexate—lymphatic system cancer	0.000552	0.00147	CcSEcCtD
Sitagliptin—Arthralgia—Methotrexate—lymphatic system cancer	0.000539	0.00143	CcSEcCtD
Sitagliptin—Myalgia—Methotrexate—lymphatic system cancer	0.000539	0.00143	CcSEcCtD
Sitagliptin—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—lymphatic system cancer	0.000535	0.00142	CcSEcCtD
Sitagliptin—Discomfort—Methotrexate—lymphatic system cancer	0.000532	0.00142	CcSEcCtD
Sitagliptin—Anaphylactic shock—Methotrexate—lymphatic system cancer	0.000517	0.00137	CcSEcCtD
Sitagliptin—Infection—Methotrexate—lymphatic system cancer	0.000513	0.00137	CcSEcCtD
Sitagliptin—Nervous system disorder—Methotrexate—lymphatic system cancer	0.000507	0.00135	CcSEcCtD
Sitagliptin—Skin disorder—Methotrexate—lymphatic system cancer	0.000502	0.00134	CcSEcCtD
Sitagliptin—Musculoskeletal discomfort—Methotrexate—lymphatic system cancer	0.000471	0.00125	CcSEcCtD
Sitagliptin—Insomnia—Methotrexate—lymphatic system cancer	0.000467	0.00124	CcSEcCtD
Sitagliptin—Somnolence—Methotrexate—lymphatic system cancer	0.000459	0.00122	CcSEcCtD
Sitagliptin—Dyspepsia—Methotrexate—lymphatic system cancer	0.000455	0.00121	CcSEcCtD
Sitagliptin—Decreased appetite—Methotrexate—lymphatic system cancer	0.000449	0.00119	CcSEcCtD
Sitagliptin—Gastrointestinal disorder—Methotrexate—lymphatic system cancer	0.000446	0.00119	CcSEcCtD
Sitagliptin—Fatigue—Methotrexate—lymphatic system cancer	0.000445	0.00119	CcSEcCtD
Sitagliptin—Pain—Methotrexate—lymphatic system cancer	0.000442	0.00118	CcSEcCtD
Sitagliptin—Feeling abnormal—Methotrexate—lymphatic system cancer	0.000426	0.00113	CcSEcCtD
Sitagliptin—Gastrointestinal pain—Methotrexate—lymphatic system cancer	0.000422	0.00112	CcSEcCtD
Sitagliptin—Urticaria—Methotrexate—lymphatic system cancer	0.00041	0.00109	CcSEcCtD
Sitagliptin—Abdominal pain—Methotrexate—lymphatic system cancer	0.000408	0.00109	CcSEcCtD
Sitagliptin—Hypersensitivity—Methotrexate—lymphatic system cancer	0.000381	0.00101	CcSEcCtD
Sitagliptin—Asthenia—Methotrexate—lymphatic system cancer	0.000371	0.000986	CcSEcCtD
Sitagliptin—Diarrhoea—Methotrexate—lymphatic system cancer	0.000353	0.000941	CcSEcCtD
Sitagliptin—Dizziness—Methotrexate—lymphatic system cancer	0.000342	0.000909	CcSEcCtD
Sitagliptin—Vomiting—Methotrexate—lymphatic system cancer	0.000328	0.000874	CcSEcCtD
Sitagliptin—Rash—Methotrexate—lymphatic system cancer	0.000326	0.000867	CcSEcCtD
Sitagliptin—Dermatitis—Methotrexate—lymphatic system cancer	0.000325	0.000866	CcSEcCtD
Sitagliptin—Headache—Methotrexate—lymphatic system cancer	0.000324	0.000861	CcSEcCtD
Sitagliptin—Nausea—Methotrexate—lymphatic system cancer	0.000307	0.000817	CcSEcCtD
